FDA approves first nasal spray flu vaccine for use at home
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before expanding eligibility in 2007 to children as young as 2 years old — requiring in both instances that it be administered by a vaccine provider.
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement activities. Some letters are not ...
“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...
The U.S. Food and Drug Administration approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, making it the ...
Investing News Network on MSN2d
FDA Finds Kratom Capsules Safe, but Questions About Concentrated Forms RemainThe FDA study involved 40 participants divided into five groups, each receiving either a placebo or escalating doses of ...
Drugmaker Cephalon had the FDA's approval to market these drugs, old under brand names like Actiq, as a sweetened lozenge on ...
The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...
Medpage Today on MSN3d
FDA Rejects NK1R Antagonist for GastroparesisSupport for the neurokinin-1 receptor (NK1R) antagonist included a negative phase III trial and a positive phase II study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback